Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
Form of adoptive transfer where cells with antitumor activity are transferred to the tumor-bearing host in order to mediate tumor regression. The lymphoid cells commonly used are lymphokine-activated killer (LAK) cells and tumor-infiltrating lymphocytes (TIL). This is usually considered a form of passive immunotherapy. (From DeVita, et al., Cancer, 1993, pp.305-7, 314)
1
Immunotherapy, Adoptive -- methods : Cellular therapy of cancer : development of gene therapy based approaches / editor, Robert E. Hawkins
Immunosuppression by the administration of increasing doses of antigen. Though the exact mechanism is not clear, the therapy results in an increase in serum levels of allergen-specific IMMUNOGLOBULIN G, suppression of specific IgE, and an increase in suppressor T-cell activity
Immunotherapy Breast Cancer : Principles of immunotherapy breast and gastrointestinal cancers : activity, mechanisms of resistance and new sensitization strategies / edited by Michele Ghidini
Immunotherapy Cancer Research : Successes and Challenges of NK Immunotherapy : Breaking Tolerance to Cancer Resistance
2021
1
Immunotherapy Colon (Anatomy) Cancer : Immune therapy for pancreatic and colon cancers / edited by Ganji Purnachandra Nagaraju, Soumya Dakshinamurthy, Sarfraz Ahmad
2025
1
Immunotherapy -- Complications. : Managing immunotherapy related organ toxicities : a practical guide / Yinghong Wang, editor
2022
1
Immunotherapy -- Congresses : Immunotherapy in 2020 : visions and trends for targeting inflammatory disease / A. Radbruch [and others], editors
Immunotherapy -- ethics : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors
Immunotherapy. : A Beginner's Guide to Targeted Cancer Treatments and Cancer Immunotherapy
2024
1
Immunotherapy Genitourinary organs Cancer : Neoadjuvant immunotherapy treatment of localized genitourinary cancers : multidisciplinary management / Andrea Necchi, Philippe E. Spiess, editors
Immunotherapy Head Cancer : Immunotherapy for head and neck cancer / Anthony T. C. Chan, Brigette B.Y. Ma, editors
2023
1
Immunotherapy HIV infections : Soluble factors mediating innate immune responses to HIV infection / edited by Massimo Alfano
2010
1
Immunotherapy Infertility, Female : Lymphocyte immunization therapy (LIT) in reproductive failures : new horizons / Mohan Raut, Mugdha Raut
2022
1
Immunotherapy -- legislation & jurisprudence : New treatments for addiction : behavioral, ethical, legal, and social questions / Committee on Immunotherapies and Sustained-Release formations for Treating Drug Addiction ; Henrick J. Harwood and Tracy G. Myers, editors
Immunotherapy Neck Cancer : Immunotherapy for head and neck cancer / Anthony T. C. Chan, Brigette B.Y. Ma, editors
2023
1
Immunotherapy Pancreas Cancer : Immune therapy for pancreatic and colon cancers / edited by Ganji Purnachandra Nagaraju, Soumya Dakshinamurthy, Sarfraz Ahmad
